Lumentum Holdings Inc. — FY2021 Form 10-K
Reporting period: Fiscal year ended July 3, 2021 (53 weeks), compared with the 52-week fiscal year ended June 27, 2020. Although the request metadata says “2020 Q4,” this filing reports FY2021 annual results and includes quarterly information.
Business context
Lumentum supplies optical and photonic products in two segments: Optical Communications (OpComms), serving telecom, datacom, consumer and industrial markets; and Commercial Lasers (Lasers), serving manufacturing, inspection and life-science applications. OpComms generated 93% of FY2021 revenue. The business is globally operated and highly exposed to international markets: 92.3% of revenue was attributed to customer shipment locations outside the United States.
Financial performance
| Metric | FY2021 | FY2020 | Change |
|---|---|---|---|
| Revenue | $1,742.8 million | $1,678.6 million | +3.8% |
| Gross profit / margin | $783.1 million / 44.9% | $650.2 million / 38.7% | Margin +6.2 percentage points |
| Operating income | $527.0 million | $204.1 million | +158% |
| Net income | $397.3 million | $135.5 million | +193% |
| Diluted EPS | $5.07 | $1.75 | +190% |
| Cash from operations | $738.7 million | $524.3 million | +$214.4 million |
| Capital expenditures | $84.8 million | $86.0 million | -$1.2 million |
Operating cash flow less capital expenditures was approximately $653.9 million in FY2021; this is a simple calculation, not a company-defined free-cash-flow measure. Reported profitability included a $207.5 million net benefit from the Coherent merger termination fee and related costs.
- OpComms: Revenue rose 7.0% to $1,620.7 million; segment gross margin increased to 51.2% from 46.5%.
- Lasers: Revenue fell 25.3% to $122.1 million, mainly from weaker demand for kilowatt-class fiber lasers; segment gross margin was 46.9%, versus 46.6%.
- Liquidity: Cash and cash equivalents were $774.3 million, and short-term investments were $1,171.7 million, totaling $1,946.0 million. Current assets were $2,436.8 million and current liabilities $664.6 million.
- Debt: Convertible notes had $1.5 billion aggregate principal outstanding and $1,180.5 million carrying value. The $450 million 2024 Notes became holder-convertible based on the stock-price test and were classified as current; the $1.05 billion 2026 Notes mature in December 2026. The prior term loan was fully repaid in FY2020.
- Capital returns: Lumentum repurchased 3.1 million shares for $241.0 million in FY2021 and authorized a further share-buyback program of up to $700 million. It does not expect to pay dividends in the foreseeable future.
Material changes versus FY2020
- Revenue growth was modest overall, with OpComms growth partly offset by the contraction in Lasers.
- Gross margin improved materially, attributed to product mix (including 3D sensing, pump lasers and high-reliability components), higher manufacturing volumes, operational improvements and exits from lower-margin product lines.
- OpComms Consumer and Industrial revenue increased $67.7 million, while Telecom and Datacom increased $37.9 million. Datacom EML chip revenue grew by more than $40 million. The gains were partly offset by lower sales from exited product lines and $14.8 million of revenue deferred amid delayed 5G deployments in China.
- R&D expense increased 8.0% to $214.5 million. The company said it expects R&D investment to increase in absolute dollars in future quarters.
- Cash and cash equivalents rose by $476.3 million, largely reflecting operating cash generation. FY2021 included $236.0 million of cash share repurchases.
Outlook, risks and unusual items
- Outlook: No specific numerical revenue or earnings guidance is provided in the filing. Management described long-term opportunities in optical networks, cloud and datacenter capacity, 5G, 3D sensing, LiDAR and laser-based manufacturing, and plans continued investment in products, technology and customer programs.
- Supply and COVID-19: Semiconductor component shortages, manufacturing constraints, logistics costs and pandemic-related disruptions could restrict shipments and reduce revenue or margins, particularly in early FY2022. Management said the duration and scale of these effects were uncertain.
- Customer concentration and trade restrictions: Apple accounted for 30.2% of revenue, Huawei 10.8% and Ciena 10.1%. U.S. export restrictions have limited sales and development activity with Huawei; weaker Huawei demand also contributed to excess and obsolete inventory charges.
- Competition and mix: Pricing pressure, product commoditization, customer consolidation, changing buying patterns and product mix may cause quarterly revenue and margin volatility.
- Coherent transaction: Coherent terminated the proposed acquisition in March 2021 and paid Lumentum a $217.6 million termination fee. After $10.1 million of related costs, the reported net benefit was $207.5 million. This is a significant non-recurring contributor to FY2021 earnings.
- Other items and contingencies: Lumentum sold a San Jose property for $23.0 million and recorded an $8.3 million gain. One Oclaro-related shareholder lawsuit remained in discovery; management said it intended to defend the case and could not rule out an adverse outcome. The auditor gave unqualified opinions on the financial statements and internal controls; inventory valuation was identified as a critical audit matter.
Important facts for investors to verify
- How much of FY2021’s earnings and operating margin improvement is sustainable apart from the $207.5 million merger termination benefit and the $8.3 million property-sale gain.
- Whether semiconductor supply constraints, delayed China 5G deployments and customer demand changes affected FY2022 shipments, backlog conversion or margins.
- Continuing revenue and receivables concentration, especially Apple’s 30.2% revenue share and the two customers representing 31% of gross accounts receivable.
- The terms, potential dilution and cash-settlement implications of the $1.5 billion principal amount of convertible notes, including the current classification of the 2024 Notes.
- Progress and remaining costs from manufacturing transfers and product-line exits, along with inventory valuation assumptions and the pending Oclaro-related litigation.